Gastroenterology; 168 (2), 2025

Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the risk of HBVr. In select cases, clinical monitoring without antiviral prophylaxis is sufficient for managi...

Texte intégral

Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease. The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expanded e...

Texte intégral

WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result of cirrhosis or hepatocellular carcinoma. Most HBV-associated deaths among adults are secondary to infections acquired at b...

Texte intégral

La guía está dirigida a profesionales médicos que trabajan en los Servicios de Gastroenterología y Medicina Interna tanto de niños como de adultos, de los diversos Servicios de Salud del país; médicos a cargo de los Programas de Trasplantes de Hígado y a profesionales no médicos: enfermeras o ma...

Texte intégral